Form 4: Quest Diagnostics SVP Mark Delaney Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, disposed of 214 shares of common stock on February 26, 2025, to cover tax withholding obligations arising from the vesting of restricted stock units.
Summary
- Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, disposed of 214 shares of common stock on February 26, 2025.
- The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units.
- The shares were disposed of at a price of $171.75 per share.
- Following the transaction, Delaney directly owns 5,983 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to stock awards.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date of transaction: Disposition of common stock. |
| 02/28/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.